SDG 17. PARTNERSHIPS FOR THE GOALS Sennay Ghebreab Founder and Scientific Director at Civic AI Lab The Netherlands
InterVenn’s Glycoproteomic-based Biomarker Signature Successfully Predicts Favorable Outcomes in Metastatic Malignant Melanoma Patients Treated with Checkpoint Inhibitors